Comparison of pre-treatment with OCPs or estradiol valerate vs. no pre-treatment prior to GnRH antagonist used for IVF cycles: An RCT

BACKGROUND: Both oral contraceptive pills (OCPs) and estradiol valerate (E2) have been used to schedule a gonadotropin-releasing hormone antagonist in vitro fertilization (IVF) cycles. Since the suppression of follicle-stimulating hormone by OCPs can stay 5-7 days after stopping the pills, it seems...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Reprod Biomed
Autors principals: Shahrokh Tehrani Nejad, Ensieh, Bakhtiari Ghaleh, Fatemeh, Eslami, Bita, Haghollahi, Fedyeh, Bagheri, Maryam, Masoumi, Masoumeh
Format: Artigo
Idioma:Inglês
Publicat: Research and Clinical Center for Infertility 2018
Matèries:
Short Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6163045/
https://ncbi.nlm.nih.gov/pubmed/30288488
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars